FSA Wealth Management’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

FSA Wealth Management’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	–	–	543
2024 Q4	$0	Buy	+100	New	–	﹤0.01%	589
2024 Q1	$0	Hold	100	–	–	﹤0.01%	640
2023 Q4	$0	Buy	+100	New	–	﹤0.01%	605

FSA Wealth Management's SCPS Position: Q1 2025 in Review

FSA Wealth Management sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q1 2025, closing a stake of 100 shares.

FSA Wealth Management first reported a position in SCPS in Q4 2023 and held it in 3 quarters. The position peaked at $0 in Q4 2024. 0 funds tracked by Wall St. Rank hold SCPS as of Q1 2025.

FSA Wealth Management reported no remaining Scopus BioPharma Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
FSA Wealth Management sold 100 Scopus BioPharma Inc. Common Stock shares in Q1 2025.
FSA Wealth Management first reported a position in Scopus BioPharma Inc. Common Stock in Q4 2023 and held it in 3 quarters.
FSA Wealth Management's Scopus BioPharma Inc. Common Stock position peaked at $0 in Q4 2024.
0 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q1 2025.

Based on FSA Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.